Benazepril / Hydrochlorothiazide Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 10 mg/12.5 mg, 20 mg/12.5 mg, 20 mg/25 mg

Reference Brands: Lotensin HCT (USA), Cibadrex (EU/UK), Benza H (India)

Category: Heart Disorder

Benazepril / Hydrochlorothiazide is a combination of an ACE inhibitor (benazepril) and a thiazide diuretic (hydrochlorothiazide) used to manage high blood pressure (hypertension). Benazepril helps relax blood vessels to improve blood flow, while hydrochlorothiazide increases the removal of excess salt and water from the body. This dual action effectively lowers blood pressure and reduces the risk of stroke, heart attack, and kidney problems. Benazepril / Hydrochlorothiazide is available in Tablets and strengths such as 10 mg/12.5 mg, 20 mg/12.5 mg, 20 mg/25 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Benazepril / Hydrochlorothiazide is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Benazepril / Hydrochlorothiazide can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Benazepril / Hydrochlorothiazide is a fixed-dose combination medication used to manage high blood pressure (hypertension). It combines Benazepril, an ACE inhibitor that relaxes blood vessels by inhibiting angiotensin II formation, with Hydrochlorothiazide, a thiazide diuretic that promotes excretion of sodium and water by the kidneys. This dual mechanism effectively lowers blood pressure, helping to reduce the risk of heart attack, stroke, and kidney-related complications.

The combination is suitable for patients who require more than one agent to achieve target blood pressure levels. It is available in oral tablet form in multiple strengths to allow individualized therapy based on patient needs and response. The medication is manufactured under stringent regulatory standards by leading pharmaceutical companies worldwide, including Novartis, Cipla, Sun Pharma, and Lupin.

Regular monitoring of blood pressure, electrolytes, and kidney function is recommended during therapy. Adverse effects may include dizziness, cough, electrolyte imbalance, and, rarely, hypotension. Benazepril / Hydrochlorothiazide remains a cornerstone in hypertension management, providing effective blood pressure control through a well-established combination therapy.